Wolverine Asset Management’s Eos Energy Enterprises Warrant EOSEW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-31,523
Closed -$55.8K – 1723
2025
Q3
$55.8K Buy
31,523
+22,867
+264% +$13.1K ﹤0.01% 1185
2025
Q2
$4.07K Sell
8,656
-48,345
-85% -$20.1K ﹤0.01% 1444
2025
Q1
$17.1K Buy
57,001
+26,158
+85% +$20.8K ﹤0.01% 1266
2024
Q4
$30.2K Sell
30,843
-46,071
-60% -$13.3K ﹤0.01% 1252
2024
Q3
$15K Buy
76,914
+52,867
+220% +$11.6K ﹤0.01% 1294
2024
Q2
$4.52K Buy
24,047
+10,192
+74% +$1.25K ﹤0.01% 1418
2024
Q1
$2.46K Buy
13,855
+4,055
+41% +$704 ﹤0.01% 1454
2023
Q4
$1.96K Buy
9,800
+4,477
+84% +$1.29K ﹤0.01% 1564
2023
Q3
$2.21K Buy
+5,323
New +$4.84K ﹤0.01% 1643
2021
Q2
– Sell
-36,983
Closed -$332K – 2224
2021
Q1
$332K Sell
36,983
-13,397
-27% -$130K ﹤0.01% 1049
2020
Q4
$418K Buy
+50,380
New +$144K ﹤0.01% 896
2020
Q3
– Sell
-106,844
Closed -$186K – 1602
2020
Q2
$186K Buy
+106,844
New +$116K ﹤0.01% 954

Wolverine Asset Management's EOSEW Position: Q4 2025 in Review

Wolverine Asset Management sold out of Eos Energy Enterprises Warrant (EOSEW) in Q4 2025, closing a stake of 31,523 shares — an estimated $55.8K sold.

Wolverine Asset Management first reported a position in EOSEW in Q2 2020 and held it in 12 quarters. The position peaked at $418K in Q4 2020. 0 funds tracked by Wall St. Rank hold EOSEW as of Q4 2025.

  • Wolverine Asset Management reported no remaining Eos Energy Enterprises Warrant position as of Q4 2025 after selling out during the quarter.
  • Wolverine Asset Management sold 31,523 Eos Energy Enterprises Warrant shares in Q4 2025, an estimated $55.8K.
  • Wolverine Asset Management first reported a position in Eos Energy Enterprises Warrant in Q2 2020 and held it in 12 quarters.
  • Wolverine Asset Management's Eos Energy Enterprises Warrant position peaked at $418K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Eos Energy Enterprises Warrant as of Q4 2025.

Based on Wolverine Asset Management's 13F filing for Q4 2025, filed 2 Feb 2026.